论文部分内容阅读
目的:分析采用辅助生育技术治疗后受孕妇女的妊娠结局。方法:回顾性分析自1999年3月至2005年11月间在我院生殖医学中心行常规体外受精-胚胎移植术(IVF-ET)、单精子卵胞浆内注射术(ICSI)、冻融胚胎移植技术(FET)及未成熟卵母细胞体外成熟培养技术(IVM)的1697个妊娠周期的结局、围产儿情况。结果:1697个妊娠周期中,生化妊娠143例,占8.43%;临床妊娠1554例,占91.57%,流产185例,占10.90%;宫外孕81例,占4.77%;宫内外同时妊娠12例,占0.71%。共分娩944例,其中早产为204例,占21.61%;分娩方式以剖腹产为主,共725例,占76.80%;双胎分娩366例,占38.77%;三胎8例,占0.847%;共分娩1326个孩子,其中男婴689个,占51.96%,女婴637个,占48.04%;早产儿409个,占30.84%;低出生体重儿372个,占28.05%;新生儿死亡6例,占0.452%,死胎6例,占0.452%,新生儿缺陷20例,占1.51%;失访114例,占6.79%。结论:经辅助生育技术治疗后多胎、早产及低出生体重儿比率高,应加强围产监护并建立完善的随访制度。
OBJECTIVE: To analyze the pregnancy outcome of pregnant women after treatment with assisted reproductive technology. Methods: From March 1999 to November 2005, we retrospectively performed routine in vitro fertilization-embryo transfer (IVF-ET), intracytoplasmic sperm injection (ICSI), freeze-thaw Outcomes of 1697 Gestational Outcomes of Embryo Transfer Technology (FET) and Immature Oocyte In Vitro Maturation Culture (IVM), Perinatal Situation. Results: Among 1697 pregnancy cycles, 143 cases were biochemical pregnancy, accounting for 8.43%; clinical pregnancy 1554 cases, accounting for 91.57%, abortion 185 cases, accounting for 10.90%; ectopic pregnancy 81 cases, accounting for 4.77%; intrauterine and external pregnancy 12 cases 0.71%. A total of 944 cases of childbirth, of which 204 cases of preterm birth, accounting for 21.61%; mode of delivery to caesarean section, a total of 725 cases, accounting for 76.80%; 366 cases of twin births, accounting for 38.77%; 8 cases of third births, accounting for 0.847%; The birth of 1326 children, of which 689 were male babies, accounting for 51.96%, 637 girls, accounting for 48.04%; 409 premature children, accounting for 30.84%; low birth weight children 372, accounting for 28.05%; neonatal death in 6 cases, Accounting for 0.452%, 6 cases of stillbirth, accounting for 0.452%, 20 cases of neonatal defects, accounting for 1.51%; lost to 114 cases, accounting for 6.79%. Conclusion: The rate of multiple births, premature birth and low birth weight children after assisted reproductive technology is high. We should strengthen perinatal care and establish a complete follow-up system.